top of page
Combating Drug Resistant Bacterial Infections
Our novel antibiotic is being developed for treatment of antibiotic resistant pathogens such as MRSA.

Sano Chemicals is focused on developing new treatments for drug-resistant infections. For the past several decades, bacteria and fungi have been acquiring resistance to current drugs, requiring the development of new drugs to stay ahead of the evolutionary curve.
Our Pipeline

bottom of page